{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:34:23Z","timestamp":1759962863524},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bpgastro.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.bpg.2014.11.005","type":"journal-article","created":{"date-parts":[[2014,11,12]],"date-time":"2014-11-12T09:45:26Z","timestamp":1415785526000},"page":"139-150","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Acid suppression and surgical therapy for Barrett's oesophagus"],"prefix":"10.1016","volume":"29","author":[{"given":"Pieter J.F.","family":"de Jonge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manon C.","family":"Spaander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco J.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst J.","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2014.11.005_bib1","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus","volume":"101","author":"Vakil","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2014.11.005_bib2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","article-title":"Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"63","author":"El-Serag","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2014.11.005_bib3","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0140-6736(12)62171-0","article-title":"Gastro-oesophageal reflux disease","volume":"381","author":"Bredenoord","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2014.11.005_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/gutjnl-2013-305490","article-title":"Barrett's oesophagus: epidemiology, cancer risk and implications for management","volume":"63","author":"de Jonge","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2014.11.005_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cgh.2009.10.010","article-title":"Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis","volume":"8","author":"Sikkema","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2014.11.005_bib6","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/gut.2009.176701","article-title":"Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study","volume":"59","author":"de Jonge","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2014.11.005_bib7","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","article-title":"Incidence of adenocarcinoma among patients with Barrett's esophagus","volume":"365","author":"Hvid-Jensen","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpg.2014.11.005_bib8","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/jnci\/djr203","article-title":"Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study","volume":"103","author":"Bhat","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.bpg.2014.11.005_bib9","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1053\/j.gastro.2005.08.053","article-title":"Prevalence of Barrett's esophagus in the general population: an endoscopic study","volume":"129","author":"Ronkainen","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2014.11.005_bib10","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1136\/gut.2007.145177","article-title":"Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study","volume":"57","author":"Zagari","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2014.11.005_bib11","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1572-0241.1998.211_a.x","article-title":"Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus","volume":"93","author":"Ouatu-Lascar","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2014.11.005_bib12","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1001\/jama.2011.626","article-title":"Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial","volume":"305","author":"Galmiche","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bpg.2014.11.005_bib13","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1053\/j.gastro.2008.08.044","article-title":"American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease","volume":"135","author":"Kahrilas","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2014.11.005_bib14","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1111\/j.1572-0241.2003.08783.x","article-title":"Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study","volume":"98","author":"Miner","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2014.11.005_bib15","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cgh.2012.11.031","article-title":"Reported side effects and complications of long-term proton pump inhibitor use: dissecting the evidence","volume":"11","author":"Johnson","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2014.11.005_bib16","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/gast.1997.v112.pm9178669","article-title":"Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis","volume":"112","author":"Chiba","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2014.11.005_bib17","first-page":"CD003244","article-title":"Medical treatments in the short term management of reflux oesophagitis","author":"Khan","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpg.2014.11.005_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2036.1997.114285000.x","article-title":"Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus","volume":"11","author":"Sontag","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2014.11.005_bib19","first-page":"1844","article-title":"Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus","volume":"89","author":"Sampliner","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2014.11.005_bib20","first-page":"582","article-title":"Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus","volume":"92","author":"Sharma","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2014.11.005_bib21","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1046\/j.1365-2036.1999.00593.x","article-title":"Regression of columnar-lined (Barrett's) oesophagus with omeprazole 40\u00a0mg daily: results of 5 years of continuous therapy","volume":"13","author":"Wilkinson","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2014.11.005_bib22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/gut.45.4.489","article-title":"Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study","volume":"45","author":"Peters","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2014.11.005_bib23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1365-2036.2001.00958.x","article-title":"Maximal acid reflux control for Barrett's oesophagus: feasible and effective","volume":"15","author":"Srinivasan","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2014.11.005_bib24","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1365-2036.2005.02406.x","article-title":"Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus","volume":"21","author":"Todd","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2014.11.005_bib25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2036.2004.02127.x","article-title":"Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors","volume":"20","author":"Gerson","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2014.11.005_bib26","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/00042737-200211000-00005","article-title":"Persistent acid reflux and symptoms in patients with Barrett's oesophagus on proton-pump inhibitor therapy","volume":"14","author":"Basu","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2014.11.005_bib27","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/j.1572-0241.2006.00661.x","article-title":"Gastric and esophageal pH in patients with Barrett's esophagus treated with three esomeprazole dosages: a randomized, double-blind, crossover trial","volume":"101","author":"Spechler","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2014.11.005_bib28","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s10620-008-0413-9","article-title":"The association between obesity and GERD: a review of the epidemiological evidence","volume":"53","author":"El-Serag","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2014.11.005_bib29","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gutjnl-2011-300641","article-title":"Association of insulin and insulin-like growth factors with Barrett's oesophagus","volume":"61","author":"Greer","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2014.11.005_bib30","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3109\/00365521.2013.799221","article-title":"The prevalence of Helicobacter pylori infection in the Netherlands","volume":"48","author":"van Blankenstein","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2014.11.005_bib31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ajg.2013.443","article-title":"Association between Helicobacter pylori and Barrett's esophagus: a case-control study","volume":"109","author":"Fischbach","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2014.11.005_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cgh.2013.08.029","article-title":"Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms","volume":"12","author":"Rubenstein","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2014.11.005_bib33","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1172\/JCI119018","article-title":"Dynamic effects of acid on Barrett's esophagus. An ex\u00a0vivo proliferation and differentiation model","volume":"98","author":"Fitzgerald","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.bpg.2014.11.005_bib34","doi-asserted-by":"crossref","first-page":"G278","DOI":"10.1152\/ajpgi.00092.2011","article-title":"Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-kappaB activation in benign Barrett's epithelial cells","volume":"301","author":"Huo","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.bpg.2014.11.005_bib35","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1046\/j.1365-2036.1999.00556.x","article-title":"The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy","volume":"13","author":"Peters","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2014.11.005_bib36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1053\/gast.1999.0029900327","article-title":"Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression","volume":"117","author":"Ouatu-Lascar","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2014.11.005_bib37","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1046\/j.1365-2036.1998.00389.x","article-title":"Continuous treatment with omeprazole 20\u00a0mg daily for up to 6 years in Barrett's oesophagus","volume":"12","author":"Cooper","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2014.11.005_bib38","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2036.1993.tb00143.x","article-title":"Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy","volume":"7","author":"Gore","year":"1993","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2014.11.005_bib39","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0016-5107(96)70055-X","article-title":"Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole","volume":"44","author":"Malesci","year":"1996","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2014.11.005_bib40","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2036.1995.tb00405.x","article-title":"Long term continuous omeprazole treatment of patients with Barrett's oesophagus","volume":"9","author":"Neumann","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2014.11.005_bib41","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.cgh.2013.05.007","article-title":"Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia","volume":"11","author":"Anaparthy","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2014.11.005_bib42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5694\/j.1326-5377.2004.tb05991.x","article-title":"Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus","volume":"180","author":"Hillman","year":"2004","journal-title":"Med J Aust"},{"key":"10.1016\/j.bpg.2014.11.005_bib43","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1572-0241.2004.30228.x","article-title":"Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus","volume":"99","author":"El-Serag","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2014.11.005_bib44","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cgh.2009.06.001","article-title":"Medication usage and the risk of neoplasia in patients with Barrett's esophagus","volume":"7","author":"Nguyen","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2014.11.005_bib45","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cgh.2012.11.014","article-title":"Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus","volume":"11","author":"Kastelein","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2014.11.005_bib46","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/gutjnl-2013-305997","article-title":"Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis","volume":"63","author":"Singh","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2014.11.005_bib47","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1007\/s00464-010-1267-8","article-title":"Guidelines for surgical treatment of gastroesophageal reflux disease","volume":"24","author":"Stefanidis","year":"2010","journal-title":"Surg Endosc"},{"key":"10.1016\/j.bpg.2014.11.005_bib48","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/bjs.7174","article-title":"Systematic review and meta-analysis of laparoscopic Nissen (posterior total) versus Toupet (posterior partial) fundoplication for gastro-oesophageal reflux disease","volume":"97","author":"Broeders","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib49","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1445-2197.2010.05481.x","article-title":"Meta-analysis of laparoscopic total (Nissen) versus posterior (Toupet) fundoplication for gastro-oesophageal reflux disease based on randomized clinical trials","volume":"81","author":"Tan","year":"2011","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib50","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cgh.2012.12.006","article-title":"Gastroesophageal reflux disease treatment: side effects and complications of fundoplication","volume":"11","author":"Richter","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2014.11.005_bib51","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.amjsurg.2004.08.062","article-title":"Failed fundoplications","volume":"188","author":"Hatch","year":"2004","journal-title":"Am J Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib52","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/bjs.6486","article-title":"Long-term outcomes of revisional surgery following laparoscopic fundoplication","volume":"96","author":"Lamb","year":"2009","journal-title":"Br J Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib53","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00000658-199810000-00011","article-title":"The impact of an antireflux procedure on intestinal metaplasia of the cardia","volume":"228","author":"DeMeester","year":"1998","journal-title":"Ann Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib54","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0003-4975(90)90298-K","article-title":"Effect of antireflux operation on Barrett's mucosa","volume":"49","author":"Williamson","year":"1990","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib55","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.SLA.0000055269.77838.8E","article-title":"Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus","volume":"237","author":"Parrilla","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib56","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/01.sla.0000090443.97693.c3","article-title":"Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery","volume":"238","author":"Oelschlager","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib57","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/00000658-200110000-00012","article-title":"Long-term outcome of antireflux surgery in patients with Barrett's esophagus","volume":"234","author":"Hofstetter","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib58","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0003-4975(03)01352-3","article-title":"Barrett's esophagus: the role of laparoscopic fundoplication","volume":"77","author":"Abbas","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00464-005-0023-y","article-title":"Laparoscopic treatment of Barrett's esophagus: long-term results","volume":"21","author":"Biertho","year":"2007","journal-title":"Surg Endosc"},{"key":"10.1016\/j.bpg.2014.11.005_bib60","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.amjsurg.2003.08.009","article-title":"Efficacy of laparoscopic antireflux surgery in patients with Barrett's esophagus","volume":"186","author":"Desai","year":"2003","journal-title":"Am J Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib61","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/SLE.0b013e31828b8758","article-title":"Two-year subjective, objective, quality of life, and endoscopic follow-up after laparoscopic Nissen-Rossetti in patients with columnar-lined esophagus","volume":"23","author":"Marano","year":"2013","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"key":"10.1016\/j.bpg.2014.11.005_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amjsurg.2003.10.025","article-title":"Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery","volume":"188","author":"O'Riordan","year":"2004","journal-title":"Am J Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/00365521.2011.639081","article-title":"The effects of laparoscopic Nissen fundoplication on Barrett's esophagus: long-term results","volume":"47","author":"Simonka","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2014.11.005_bib64","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s11605-010-1322-8","article-title":"Long-term follow-up after anti-reflux surgery in patients with Barrett's esophagus","volume":"14","author":"Zehetner","year":"2010","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib65","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00464-005-0434-9","article-title":"Histologic and clinical outcome after laparoscopic Nissen fundoplication for gastroesophageal reflux disease and Barrett's esophagus","volume":"20","author":"Ozmen","year":"2006","journal-title":"Surg Endosc"},{"key":"10.1016\/j.bpg.2014.11.005_bib66","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.gassur.2005.09.027","article-title":"Barrett's epithelium after antireflux surgery","volume":"9","author":"Zaninotto","year":"2005","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib67","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/archsurg.2009.83","article-title":"Late results of the surgical treatment of 125 patients with short-segment Barrett esophagus","volume":"144","author":"Csendes","year":"2009","journal-title":"Arch Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib68","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1072-7515(02)01502-8","article-title":"Impact of antireflux operation on columnar-lined esophagus","volume":"196","author":"Mabrut","year":"2003","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib69","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S1091-255X(02)00033-1","article-title":"Clinical and histologic follow-up after antireflux surgery for Barrett's esophagus","volume":"6","author":"Bowers","year":"2002","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib70","article-title":"Antireflux surgery for dysplastic Barrett","author":"Allaix","year":"2014","journal-title":"World J Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib71","doi-asserted-by":"crossref","first-page":"95","DOI":"10.9738\/CC29.1","article-title":"Laparoscopic surgical treatment for patients with short- and long-segment Barrett's esophagus: which technique in which patient?","volume":"96","author":"Braghetto","year":"2011","journal-title":"Int Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib72","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.sla.0000261459.10565.e9","article-title":"The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review","volume":"246","author":"Chang","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib73","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1111\/j.1572-0241.2003.08702.x","article-title":"Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis","volume":"98","author":"Corey","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2014.11.005_bib74","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1442-2050.2008.00886.x","article-title":"Treatment modality and risk of development of dysplasia and adenocarcinoma in columnar-lined esophagus","volume":"22","author":"Gatenby","year":"2009","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.bpg.2014.11.005_bib75","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/bjs.1800830242","article-title":"Conservative treatment versus antireflux surgery in Barrett's oesophagus: long-term results of a prospective study","volume":"83","author":"Ortiz","year":"1996","journal-title":"Br J Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib76","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.amjsurg.2008.11.032","article-title":"Differential molecular changes in patients with asymptomatic long-segment Barrett's esophagus treated by antireflux surgery or medical therapy","volume":"199","author":"Babar","year":"2010","journal-title":"Am J Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib77","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/SLA.0b013e3181e4181c","article-title":"The effect of long-term control of reflux by fundoplication on aberrant deoxyribonucleic acid methylation in patients with Barrett esophagus","volume":"252","author":"Smith","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.bpg.2014.11.005_bib78","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000357184","article-title":"Does Barrett's esophagus regress after surgery (or proton pump inhibitors)?","volume":"32","author":"Spechler","year":"2014","journal-title":"Dig Dis"}],"container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691814001632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691814001632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T02:09:06Z","timestamp":1650593346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691814001632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1521691814001632"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2014.11.005","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acid suppression and surgical therapy for Barrett's oesophagus","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2014.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}